Michael P. East

1.9k total citations
37 papers, 1.1k citations indexed

About

Michael P. East is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Michael P. East has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Michael P. East's work include Cancer-related Molecular Pathways (7 papers), Microtubule and mitosis dynamics (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Michael P. East is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Microtubule and mitosis dynamics (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Michael P. East collaborates with scholars based in United States, Finland and United Kingdom. Michael P. East's co-authors include Richard Kahn, Tamara Caspary, Christine E. Larkins, Christopher R. M. Asquith, Hari Krishna Sajja, Hui Mao, Lily Yang, Yiqing Wang, Shuming Nie and Tuomo Laitinen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Chemistry.

In The Last Decade

Michael P. East

37 papers receiving 1.1k citations

Peers

Michael P. East

GENET

ONCOL

BIOMA

Chengcheng Huang China

Nicolas Floquet France

Sheila S. Teves United States

Alexandra K. Gardino United States

Kuang‐Lei Tsai United States

Andreas Kremer Netherlands

Qing Lin United States

Hongliang Zong China

Berndt Oberhauser Austria

Zhi Sheng United States

Chengcheng Huang China

Michael P. East

644 ×0.8

190 ×0.7

GENET

217 ×0.9

124 ×1.0

ONCOL

141 ×1.4

BIOMA

Citations per year, relative to Michael P. East Michael P. East (= 1×) peers Chengcheng Huang

Countries citing papers authored by Michael P. East

Since Specialization

Citations

This map shows the geographic impact of Michael P. East's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. East with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. East more than expected).

Fields of papers citing papers by Michael P. East

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. East. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. East. The network helps show where Michael P. East may publish in the future.

Co-authorship network of co-authors of Michael P. East

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. East. A scholar is included among the top collaborators of Michael P. East based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. East. Michael P. East is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matkar, Smita, Michael P. East, Timothy J. Stuhlmiller, et al.. (2025). Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma. Molecular Cancer Therapeutics. 24(9). 1389–1401. 2 indexed citations

Asquith, Christopher R. M., Michael P. East, Tuomo Laitinen, et al.. (2024). Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships. European Journal of Medicinal Chemistry. 271. 116357–116357. 1 indexed citations

Asquith, Christopher R. M., Michael P. East, Tuomo Laitinen, et al.. (2022). Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**. ChemMedChem. 17(12). e202200161–e202200161. 3 indexed citations

Saul, Sirle, Luca Ghita, Malaya K. Sahoo, et al.. (2022). Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies. Antiviral Research. 204. 105367–105367. 24 indexed citations

Asquith, Christopher R. M., Michael P. East, Robert Smith, et al.. (2022). Small-molecule inhibition of the archetypal UbiB protein COQ8. Nature Chemical Biology. 19(2). 230–238. 7 indexed citations

East, Michael P. & Gary L. Johnson. (2021). Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition. Journal of Biological Chemistry. 298(2). 101525–101525. 9 indexed citations

Grant, Gavin D., Michael P. East, Thomas S.K. Gilbert, et al.. (2020). Mass spectrometry–based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells. Journal of Biological Chemistry. 295(8). 2359–2374. 16 indexed citations

Dewar, Brian J., Michael P. East, Katherine Tech, et al.. (2019). Lyn regulates creatine uptake in an imatinib-resistant CML cell line. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(4). 129507–129507. 5 indexed citations

Asquith, Christopher R. M., Tuomo Laitinen, & Michael P. East. (2019). PKMYT1: a forgotten member of the WEE1 family. Nature Reviews Drug Discovery. 19(3). 157–157. 25 indexed citations

10.

Asquith, Christopher R. M., Benedict‐Tilman Berger, James M. Bennett, et al.. (2019). SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK). Journal of Medicinal Chemistry. 62(5). 2830–2836. 45 indexed citations

11.

Lee, Benjamin, Michael P. East, Thomas S.K. Gilbert, et al.. (2018). Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. SLAS DISCOVERY. 23(8). 850–861. 13 indexed citations

12.

East, Michael P., Laura E. Herring, Raymond Zhang, et al.. (2017). BIRC6 mediates imatinib resistance independently of Mcl-1. PLoS ONE. 12(5). e0177871–e0177871. 15 indexed citations

13.

Asquith, Christopher R. M., Tuomo Laitinen, James M. Bennett, et al.. (2017). Identification and Optimization of 4‐Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase. ChemMedChem. 13(1). 48–66. 38 indexed citations

14.

Choi, Soo Young, Noémi Polgár, Michael P. East, et al.. (2015). Arl13b and the exocyst interact synergistically in ciliogenesis. Molecular Biology of the Cell. 27(2). 308–320. 60 indexed citations

15.

Ivanova, Anna, et al.. (2014). Characterization of Recombinant ELMOD (Cell Engulfment and Motility Domain) Proteins as GTPase-activating Proteins (GAPs) for ARF Family GTPases. Journal of Biological Chemistry. 289(16). 11111–11121. 40 indexed citations

16.

East, Michael P., J. Bradford Bowzard, Joel B. Dacks, & Richard Kahn. (2012). ELMO Domains, Evolutionary and Functional Characterization of a Novel GTPase-activating Protein (GAP) Domain for Arf Protein Family GTPases. Journal of Biological Chemistry. 287(47). 39538–39553. 46 indexed citations

17.

Larkins, Christine E., et al.. (2011). Arl13b regulates ciliogenesis and the dynamic localization of Shh signaling proteins. Molecular Biology of the Cell. 22(23). 4694–4703. 222 indexed citations

18.

East, Michael P. & Richard Kahn. (2010). Models for the functions of Arf GAPs. Seminars in Cell and Developmental Biology. 22(1). 3–9. 52 indexed citations

19.

East, Michael P.. (2010). A role for cigarette fumes in the development of emphysema through reduced alveolar cell proliferation and upregulation of apoptosis. Thorax. 66(6). 473–473. 1 indexed citations

20.

Sajja, Hari Krishna, Michael P. East, Hui Mao, et al.. (2009). Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect. Current Drug Discovery Technologies. 6(1). 43–51. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact